Business Description
Pfizer Inc
NAICS : 325412
SIC : 2834
ISIN : CA7170651060
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 7.41 | |||||
Interest Coverage | 1.52 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.66 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | -10.4 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | -26.8 | |||||
3-Year Book Growth Rate | 11.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | -1.33 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.67 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.75 | |||||
9-Day RSI | 38.02 | |||||
14-Day RSI | 37.59 | |||||
6-1 Month Momentum % | -11.87 | |||||
12-1 Month Momentum % | -32.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 144 | |||||
Days Sales Outstanding | 69.57 | |||||
Days Payable | 90.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.41 | |||||
Dividend Payout Ratio | 0.82 | |||||
3-Year Dividend Growth Rate | 2.6 | |||||
Forward Dividend Yield % | 6.47 | |||||
5-Year Yield-on-Cost % | 7.85 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | -8.96 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.34 | |||||
Operating Margin % | 5.74 | |||||
Net Margin % | 3.62 | |||||
FCF Margin % | 8.22 | |||||
ROE % | 2.2 | |||||
ROA % | 1 | |||||
ROIC % | 3.81 | |||||
ROC (Joel Greenblatt) % | 18.64 | |||||
ROCE % | 1.89 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 72.22 | |||||
Forward PE Ratio | 10.36 | |||||
PE Ratio without NRI | 14.21 | |||||
Shiller PE Ratio | 9.57 | |||||
Price-to-Owner-Earnings | 406.25 | |||||
PEG Ratio | 1.75 | |||||
PS Ratio | 2.53 | |||||
PB Ratio | 1.65 | |||||
Price-to-Free-Cash-Flow | 30.44 | |||||
Price-to-Operating-Cash-Flow | 16.87 | |||||
EV-to-EBIT | 62.87 | |||||
EV-to-Forward-EBIT | 12.78 | |||||
EV-to-EBITDA | 21.49 | |||||
EV-to-Forward-EBITDA | 10.72 | |||||
EV-to-Revenue | 3.51 | |||||
EV-to-Forward-Revenue | 3.42 | |||||
EV-to-FCF | 42.85 | |||||
Price-to-Projected-FCF | 0.46 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.66 | |||||
Earnings Yield (Greenblatt) % | 1.59 | |||||
FCF Yield % | 3.26 | |||||
Forward Rate of Return (Yacktman) % | 31.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pfizer Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 78,954.33 | ||
EPS (TTM) (C$) | 0.192 | ||
Beta | 0 | ||
Volatility % | 11.87 | ||
14-Day RSI | 37.59 | ||
14-Day ATR (C$) | 0.209825 | ||
20-Day SMA (C$) | 12.536 | ||
12-1 Month Momentum % | -32.06 | ||
52-Week Range (C$) | 11.84 - 19.33 | ||
Shares Outstanding (Mil) | 14,709.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pfizer Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pfizer Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Pfizer Inc Frequently Asked Questions
What is Pfizer Inc(NEOE:PFE)'s stock price today?
When is next earnings date of Pfizer Inc(NEOE:PFE)?
Does Pfizer Inc(NEOE:PFE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |